Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (56)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schouten, W. E. M.
Right arrow Articles by Nubé, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schouten, W. E. M.
Right arrow Articles by Nubé, M. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2000) 15: 379-384
© 2000 European Renal Association-European Dialysis and Transplant Association

Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis

Wilhelmina E. M. Schouten1, Muriel P. C. Grooteman1, Arend-Jan van Houte1, Margreet Schoorl1, Jacques van Limbeek2 and Menso J. Nubé1

1 Departments of Haemodialysis and Immunohematology, Medical Centre Alkmaar and 2 St Maartenskliniek, Nijmegen, The Netherlands

Correspondence and offprint requests to: Wilhelmina E. M. Schouten MD, Medical Centre Alkmaar, Wilhelminalaan 12, 1815 JD Alkmaar, The Netherlands.

Background. In chronic haemodialysis (HD), morbidity may result from repetitive induction of the acute phase response, caused by a bioincompatible dialysis membrane and/or contaminated dialysate. In the present study, cytokine release (interleukin-6, IL-6) and subsequent production of acute phase proteins (C-reactive protein, CRP and secretory phospholipase A2, sPLA2) were assessed to investigate whether the HD-induced acute phase reaction depends mainly on the type of membrane or on the sterility of the dialysate.

Methods. In 11 patients, IL-6, CRP and sPLA2 levels were assessed in blood samples drawn before (t0), at the end (t180) and 24 h after the start of HD (t1440). All patients were dialysed on Cuprammonium (CU) and Polysulphon (PS) dialysers and seven patients underwent an additional HD session on CU plus a dialysate filter (CUf).

Results. IL-6 levels were increased significantly at t180 compared with t0 (P<0.02) with both CU and CUf. At t1440, IL-6 levels had returned to baseline. In contrast, marked fluctuations did not occur during HD with PS. At t180, IL-6 was significantly greater with CU and CUf devices, than with PS (P<0.02). Following HD with CU and CUf, a significant increase in CRP was observed at t1440, compared with postdialysis values (P<=0.05). In addition, sPLA2 values were markedly increased at t1440, compared with t180, but only significant in the case of CU (P=0.01). IL-6 levels at t180 were significantly correlated with CRP (r=0.50, P<0.01) and sPLA2 (r=0.47, P=0.01) values at t1440. During HD with PS membranes, neither CRP nor sPLA2 values were markedly changed.

Conclusions. In contrast to PS, both CU and CUf resulted in elevated IL-6 plasma levels at the end of HD, compared with t0, which correlated with increased CRP and sPLA2 values 24 h later. Therefore, the type of membrane, rather than the bacterial quality of the dialysate, seems to be responsible for the induction of the acute phase response during clinical bicarbonate HD.

Keywords: acute phase response; bioincompatibility; C-reactive protein; haemodialysis; interleukin-6; secretory phospholipase A2


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
V. Panichi, G. M. Rizza, S. Paoletti, R. Bigazzi, M. Aloisi, G. Barsotti, P. Rindi, G. Donati, A. Antonelli, E. Panicucci, et al.
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2337 - 2343.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. Vanholder, N. Meert, E. Schepers, G. Glorieux, A. Argiles, P. Brunet, G. Cohen, T. Drueke, H. Mischak, G. Spasovski, et al.
Review on uraemic solutes II Variability in reported concentrations: causes and consequences
Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3115 - 3121.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Boure and R. Vanholder
Which dialyser membrane to choose?
Nephrol. Dial. Transplant., February 1, 2004; 19(2): 293 - 296.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Virga, I. Visentin, V. La Milia, and A. Bonadonna
Inflammation and pruritus in haemodialysis patients
Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2164 - 2169.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. J. Nube and M. P. C. Grooteman
Impact of contaminated dialysate on long-term haemodialysis-related complications: is it really that important?
Nephrol. Dial. Transplant., October 1, 2001; 16(10): 1986 - 1991.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Bommer
Sterile filtration of dialysate: is it really of no use?
Nephrol. Dial. Transplant., October 1, 2001; 16(10): 1992 - 1994.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Locatelli, J. Bommer, G. M. London, A. Martin-Malo, C. Wanner, M. Yaqoob, and C. Zoccali
Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment
Nephrol. Dial. Transplant., March 1, 2001; 16(3): 459 - 468.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.